Strategy game supporting goal management training interventio
- Conditions
- Acquired brain injury
- Registration Number
- NL-OMON26575
- Lead Sponsor
- The European Regional Development Fund (ERDF)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 64
Patients will be eligible if they have sustained any type of acquired brain injury of non-progressive nature in the past, being more than three months post injury and if their executive function score on the BRIEF-A is clinically meaningful. Other inclusion criteria are: (1) aged between 18 and 70 years; (2) referred for outpatient rehabilitation and (3) living independently at home.
Exclusion criteria are: (1) inability to speak/ understand the Dutch language; (2) co-morbidity that might affect outcome (e.g. neurodegenerative disorders, aphasia, neglect, and major psychiatric illness); (3) substance abuse; (4) no access to a smartphone, laptop or tablet; (5) unable to look at a computer screen for 15 minutes; and (6) being unable to operate a keyboard or computer mouse.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The main study parameter is a standardized scale measuring performance of an untrained IADL task (int. al. the percent change in the number of correct steps) before (baseline) and after treatment (post treatment). The untrained IADL tasks will be divided into multiple steps using the GMT method. These steps will be assessed using three categories: 1) competent; 2) questionable/ineffective; 3) deficit, using task-specific assessment forms.<br><br>In order to assess the secondary objective of the study, patients also perform an untrained IADL task at 3 months follow-up. The order of the untrained tasks will be counterbalanced across patients.
- Secondary Outcome Measures
Name Time Method <br>Secondary study parameters of the study are the performance on two trained IADL tasks and the subjective experience of strategy use. Moreover, questionnaires and neuropsychological tests will be administered. All measurements will be administered at baseline, post-treatment and at 3 months follow-up.